SciELO - Scientific Electronic Library Online

 
vol.83 número3Avaliação do conhecimento médico em hidradenite supurativa: impacto da formação médica contínua nos médicos portuguesesPapilomatose confluente e reticulada de Gougerot-Carteaud tratada com azitromicina com excelente resultado índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Portuguese Journal of Dermatology and Venereology

versão impressa ISSN 2795-501Xversão On-line ISSN 2795-5001

Port J Dermatol Venereol. vol.83 no.3 Lisboa set. 2025  Epub 30-Set-2025

https://doi.org/10.24875/pjdv.25000034 

ORIGINAL ARTICLE

Exploring the association between acne and metabolic syndrome in patients from North-Eastern India: a cross-sectional study in a tertiary care setting

Explorando a associação entre acne e síndrome metabólica em doentes do nordeste da Índia: um estudo transversal num ambiente de cuidados terciários

Shikha Verma1 

Aniket Goswami1  * 

Binod K. Thakur2 

Kaustubh Bora3 

Alice A. Ruram4 

1Department of Dermatology, NEIGRIHMS, Shillong, Meghalaya

2Department of Dermatology and STD, Nazareth Hospital, Shillong, Meghalaya

3Division of Biochemistry and Molecular Genetics, ICMR-RMRCNE, Dibrugarh, Assam

4Department of Biochemistry, NEIGRIHMS, Shillong, Meghalaya. India


Abstract

Objectives:

Acne vulgaris is increasingly considered not just as a dermatological condition, but as a manifestation of broader systemic disturbances, including metabolic imbalance and hormonal dysregulation, with emerging evidence linking it to insulin resistance and metabolic syndrome. This study aimed to evaluate the prevalence of metabolic syndrome and insulin resistance among patients with acne vulgaris in a tertiary care setting in North-Eastern India, and to explore their relation with acne severity, body mass index (BMI), and selected biochemical parameters.

Methods:

A cross-sectional study was conducted in acne patients attending the outpatient department of dermatology at a tertiary care center in North-Eastern India. Clinical grading of acne severity was performed, along with anthropometric assessments and biochemical evaluation, which included serum insulin, fasting glucose, thyroid function, sex hormones, and vitamin D levels. Metabolic syndrome was diagnosed based on standard clinical criteria, and insulin resistance was calculated using the homeostasis model assessment. Associations were analyzed using non-parametric statistical tests, with a significance threshold of p < 0.01.

Results:

Among the 73 participants, mean age 22.2 ± 3.85 years, the majority (35.6%, n = 26) with a severe acne, 31.5% (n = 23) were overweight or obese, but only 5.47% (n = 4) met the diagnostic criteria for metabolic syndrome and 6.85% (n = 5) for insulin resistance. Despite the elevated BMI in a subset, no statistically significant association was observed between acne severity and either metabolic syndrome or insulin resistance.

Conclusion:

In this studied population, no significant association was found between acne severity and metabolic syndrome or insulin resistance, and these findings highlight acne’s complex and context-dependent pathophysiology. Given the study’s limitations (cross-sectional design and lack of matched controls), results should be interpreted within the region’s unique clinical and nutritional landscape. Further research is needed in diverse populations, particularly in under-represented regions.

Keywords Acne vulgaris; Metabolic syndrome; Insulin resistance; Body mass index; Mechanistic target of rapamycin complex 1

Resumo

Objectivos:

A acne vulgar é cada vez mais considerada não só uma condição dermatológica, mas também uma manifestação de distúrbios sistémicos mais amplos, incluindo o desequilíbrio metabólico e a desregulação hormonal, com evidências emergentes que a associam à resistência à insulina e à síndrome metabólica. Este estudo teve como objetivo avaliar a prevalência da síndrome metabólica e da resistência à insulina entre os doentes com acne vulgar num ambiente de cuidados terciários no nordeste da Índia e explorar a sua relação com a gravidade da acne, o índice de massa corporal e parâmetros bioquímicos selecionados.

Métodos:

Foi realizado um estudo transversal em doentes com acne atendidos no ambulatório de Dermatologia de um centro de cuidados terciários no nordeste da Índia. Foi realizada a classificação clínica da gravidade da acne, juntamente com avaliações antropométricas e bioquímicas, que incluíram a insulina sérica, a glicemia em jejum, a função tiroideia, as hormonas sexuais e os níveis de vitamina D. A síndrome metabólica foi diagnosticada com base em critérios clínicos padrão e a resistência à insulina foi calculada através do modelo de avaliação da homeostasia. As associações foram analisadas através de testes estatísticos não paramétricos, com um limiar de significância de p < 0.01.

Resultados:

Entre os 73 participantes, com uma média de idades de 22.2 ± 3.85 anos, a maioria (35.6%, n = 26) apresentava acne grave, 31.5% (n = 23) tinham excesso de peso ou obesidade, mas apenas 5.47% (n = 4) preenchiam os critérios de diagnóstico de síndrome metabólica e 6.85% (n = 5) de resistência à insulina. Apesar do índice de massa corporal elevado num subconjunto, não foi observada uma associação estatisticamente significativa entre a gravidade da acne e a síndrome metabólica ou a resistência à insulina.

Conclusão:

Nesta população estudada, não foi encontrada uma associação significativa entre a gravidade da acne e a síndrome metabólica ou a resistência à insulina, e estes achados realçam a fisiopatologia complexa e dependente do contexto da acne. Dadas as limitações do estudo (desenho transversal e ausência de controlos emparelhados), os resultados devem ser interpretados dentro do cenário clínico e nutricional único da região. São necessárias mais pesquisas em populações diversas, particularmente em regiões sub-representadas.

Palavras-chave Acne vulgar; Síndrome metabólico; Resistência à insulina; IMC (índice de massa corporal); Alvo mecanístico do complexo 1 da rapamicina

Introduction

Acne vulgaris is a multifactorial, chronic inflammatory disorder of the pilosebaceous unit. Pathogenesis involves an interplay of factors, including hyperkeratinization of the follicular ostium, increased sebum production, bacterial colonization (primarily by Cutibacterium acnes), inflammation, hormonal influences, diet, and genetic predisposition. While many patients with acne present with normal androgen levels, conditions such as polycystic ovarian syndrome (PCOS) and congenital adrenal hyperplasia may lead to androgen excess and acne exacerbation1.

Metabolic syndrome is a cluster of interrelated conditions, including insulin resistance, central obesity, dyslipidemia, and hypertension, and has been increasingly associated with chronic inflammatory skin disorders, including acne. Both conditions share common pathophysiological mechanisms, such as chronic inflammation, oxidative stress, and hormonal dysregulation2.

Metabolic syndrome is driven by insulin resistance in muscle, fat, and liver cells, exacerbated by visceral obesity and elevated free fatty acids. This leads to increased glucose, triglycerides, and very low-density lipoproteins, creating a vicious cycle of insulin oversecretion and lipolysis. Oxidative stress from impaired sebum scavenging mechanisms further links lipid abnormalities to metabolic syndrome. Hormonal imbalances secondary to hyperinsulinism and insulin resistance can trigger androgen-dependent skin conditions such as acne and hirsutism. Inflammatory cytokines such as interleukin-17 and Tumor Necrosis Factor alpha (TNF-α) that are implicated in psoriasis and atopic dermatitis3 may also possibly contribute to a metabolic syndrome in acne. While some studies have reported a higher prevalence of metabolic syndrome among acne patients4, the overall evidence remains inconsistent. Notably, the role of dietary factors, particularly high glycemic index diets, in acne remains a subject of ongoing debate, with conflicting findings in the literature. In North-Eastern India, where rice and carbohydrate-rich staples predominate, the possibility of this association warrants a closer investigation. There is a lack of data from this geographically and ethnically distinct region of India, where unique dietary patterns and lifestyle factors may influence the development of acne and its potential systemic associations. Understanding and evaluating the relationship between acne and metabolic syndrome in this context may aid in early diagnosis and provide opportunities for integrated treatment strategies targeting both cutaneous and systemic aspects of the disease.

Methods

A cross-sectional observational study was conducted over a period of 1 year in the dermatology outpatient department of a tertiary care teaching hospital in North-Eastern India, after receiving approval from the Institutional Ethics Committee. All eligible adult patients presenting with acne vulgaris and/or truncal acne were recruited through consecutive sampling after obtaining written informed consent. The exclusion criteria involved patients who were diagnosed with PCOS, female patients with irregular menstruation history, amenorrhea or oligomenorrhea, hirsutism, associated male pattern baldness, pregnancy, and acne patients who have taken isotretinoin in the last 3 months.

A detailed assessment of the patient’s demographic profile, clinical history, and clinical evaluation was done based on a predefined pro forma. Dietary practices were assessed using a structured 7-day recall method, wherein participants were asked to report the number of servings per week for common food items such as vegetables, fruits, chicken, pork, beef, and fish. Participants also provided information on the primary type of cooking oil used at home (e.g., refined oil, mustard oil). The recall focused solely on weekly serving frequency and oil type; detailed portion sizes or nutrient quantification were not assessed. No validated dietary assessment tool was used, which is acknowledged as a limitation. Physical activity was similarly evaluated using a 7-day recall approach. Patients were asked to report engagement in moderate-intensity activities such as brisk walking, cycling at a regular pace, gardening, vacuuming, and doubles tennis. Data were recorded in terms of frequency (days per week) and approximate duration (minutes or hours per day), based on patient-reported estimates. Body mass index (BMI) was calculated and graded according to the recommendations of the Asia-pacific task force: underweight (< 18.5 kg/m2), normal weight (18.5-22.9 kg/m2), overweight (23.0-24.9 kg/m2), and obesity class I (25.0-29.9 kg/m2), and obesity class II (≥ 30.0 kg/m2).

Severity of acne was calculated using the global acne grading system5 by a single dermatologist, which involves dividing the face (including the forehead, both cheeks, the nose, and the chin), chest, and back into six specific regions. The severity of lesions in each area is rated on a scale from 0 to 4, where 0 indicates no lesions, 1 represents comedones, 2 denotes papules, 3 signifies pustules, and 4 corresponds to nodules. After assigning scores for all six regions, the total score is calculated, which is then used to classify acne severity as mild (1-18), moderate (19-30), severe (31-38), or very severe (> 39). Assessment of laboratory parameters was done after overnight fasting for 8 h and included measurement of blood sugar, lipid profile (cholesterol, triglycerides, and high-density lipoprotein [HDL]), uric acid, thyroid profile (thyroid-stimulating hormone [TSH]), vitamin D3, testosterone, dehydroepiandrosterone sulfate (DHEAS), estradiol, and insulin.

Insulin resistance was defined using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) using the formula: fasting insulin (in micro-units per milliliter) multiplied by fasting glucose (in milligrams per deciliter), then divided by 405. Values exceeding 2.5 were considered to be suggestive of insulin resistance6.

Metabolic syndrome was diagnosed using the guidelines established by the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III)7. The criteria include the presence of any three or more of the following five risk factors:

  • – Central obesity, indicated by a waist circumference of at least 102 cm for men and 88 cm for women (adjusted for Asian populations to > 90 cm and 80 cm, respectively)

  • – Triglyceride levels of 150 mg/dL or higher, or the use of medication for elevated triglycerides

  • – HDL cholesterol levels below 40 mg/dL, or medication for low HDL levels

  • – A blood pressure of 130/85 mmHg or above, or the use of antihypertensive medication

  • − A fasting plasma glucose level of 100 mg/dL or higher, or the use of medication to treat diabetes mellitus.

It is important to note that fasting insulin levels are not included in the NCEP-ATP III criteria. Instead, waist circumference is utilized as a surrogate marker, given its strong correlation with insulin resistance8.

The data were entered in a Microsoft Excel sheet (Microsoft® Excel for Mac Version 16.98 [25060824]) and analyzed using Jamovi software (version 2.6.25.0)9. Categorical variables were expressed as absolute frequencies and relative frequencies (percentages), whereas continuous variables were summarized as mean ± standard deviation or median with interquartile range, depending on data distribution. Associations between grades of acne or BMI with categorical variables such as metabolic syndrome and insulin resistance were assessed using the Mann-Whitney U test. Fisher’s exact test was employed to evaluate associations between binary variables due to the small number of positive outcomes. Comparisons of continuous biochemical parameters across acne severity grades were performed using the Kruskal-Wallis test. While logistic and ordinal regression models were considered to explore adjusted associations, they were not performed due to the limited number of outcome events. A p < 0.01 was considered statistically significant.

Results

A total of 73 adult patients were included in the study. The patients ranged from 18 to 35 years with a median age of 21 years (interquartile range: 19-25 years) and a mean age of 22.2 ± 3.85. Approximately 70% (n = 51) of the patients were female, with a M:F ratio of 0.43. The majority (82.2%, n = 60) of patients belonged to an urban background.

Acne vulgaris was seen in 50.7% (n = 37), followed by 37% (n = 27) having both acne vulgaris and truncal acne, and the remaining 12.3% (n = 09) had isolated truncal acne. Out of all, the majority (35.6%, n = 26) had a severe grade of acne (Fig. 1). The duration of the disease ranged from 1 month to 15 years, with a median duration of 3 years (interquartile range: 2-5 years).

Figure 1 Distribution of acne severity grades by sex. 

A positive family history of chronic non-communicable diseases (including diabetes mellitus and hypertension) was found in 39.7% (n = 29). Furthermore, 21.9% (n = 16) and 11% (n = 8) patients gave a history of chronic alcohol consumption and smoking, respectively.Almost 50.7% (n = 37) of patients gave a history of consumption of home-cooked food, out of which 54.8% (n = 40) had three servings and 43.8% (n = 32) had at least two servings. The majority of patients had vegetables on all days of the week with occasional servings of non-vegetarian meals (Table 1). Refined oil and mustard oil were commonly used for home-based cooking (Fig. 2).

Table 1 Distribution of weekly servings of major food groups by sex 

Servings Sex n Mean Standard deviation Minimum Maximum
Vegetables Female 51 6.176 1.466 2 7
Male 22 5.636 1.891 1 7
Fruits Female 51 3.176 2.260 0 7
Male 22 2.591 1.894 0 7
Chicken Female 51 2.157 1.901 0 7
Male 22 2.136 1.521 0 6
Pork Female 51 1.176 1.852 0 7
Male 22 0.227 0.528 0 2
Beef Female 51 1.078 1.440 0 7
Male 22 0.909 1.688 0 7
Fish Female 51 1.588 1.663 0 7
Male 22 1.682 1.729 0 7

Figure 2 Distribution of cooking oil preferences among study participants. 

Mean moderate physical activity was 1.27 days/week and 11.37 min spent/day (Table 2).

Table 2 Distribution of physical activity and anthropometric variables by sex 

Variable Sex n Mean Standard deviation Minimum Maximum
Moderate physical activity (minutes/day) Female 51 3.333 10.280 0 60
Male 22 30.000 50.710 0 180
Moderate physical activity (days/week) Female 51 0.765 1.830 0 7
Male 22 2.455 3.080 0 7
10 min walk (days/week) Female 51 4.157 3.100 0 7
Male 22 5.182 2.920 0 7
Walks (minutes/day) Female 51 36.275 47.460 0 180
Male 22 55.682 70.670 0 240
Leisure/sitting in a week (hours/day) Female 51 5.784 2.370 1 12
Male 22 6.364 2.340 1 12
Waist circumference (in centimetres) Female 51 80.200 10.690 63 116
Male 22 78.700 9.320 63 93
Hip circumference (in centimetres) Female 51 90.700 8.250 73 121
Male 22 91.400 8.160 73 104
Weight (in kilograms) Female 51 53.500 10.930 39 99
Male 22 59.500 9.700 41 79
Height (in centimetres) Female 51 155.100 5.460 143 168
Male 22 167.300 5.900 149 178
Systolic blood pressure (mmHg) Female 51 111.800 9.260 90 138
Male 22 121.100 16.130 100 180
Diastolic blood pressure (mmHg) Female 51 73.500 7.490 60 90
Male 22 80.400 10.320 60 100

Anthropometry revealed 35.29% (n = 18) of females and 13.63% (n = 3) of males had a waist circumference of > 80 cm and > 90 cm, respectively. Furthermore, 12.32% (n = 9) of patients had a blood pressure of > 130/85 mmHg (Table 2).

The median BMI was 20.93 kg/m2 (interquartile range: 19.27-23.99 kg/m2). Among female participants (n = 51), 7 (13.7%) were underweight, 27 (52.9%) had normal weight, 6 (11.8%) were overweight, 9 (17.6%) were classified as Obesity Class I, and 2 (3.9%) as Obesity Class II. Among males (n = 22), 3 (13.6%) were underweight, 13 (59.1%) had normal weight, 2 (9.1%) were overweight, and 4 (18.2%) were classified as Obesity Class I, with none in Obesity Class II. Overall, 8 participants (11.0%) were overweight and 15 (20.5%) were obese, resulting in a combined prevalence of 31.5% with elevated BMI.

The biochemical profile of participants was comprehensively evaluated across acne severity grades. No consistent or clinically meaningful differences were observed in serum uric acid, TSH, DHEAS, insulin, fasting blood glucose, total cholesterol, triglycerides, HDL, estradiol, or testosterone levels (all p > 0.01, Kruskal-Wallis test). Only serum vitamin D levels approached statistical significance (p = 0.011, Kruskal-Wallis test), though this did not meet the predefined threshold of p < 0.01 (Table 3). When categorized using clinical reference standards, vitamin D deficiency (< 20 ng/mL) was observed in 52 participants (71.2%), insufficiency (20-29 ng/mL) in 18 participants (24.7%), and sufficiency (≥ 30 ng/mL) in only 3 participants (4.1%). No cases of vitamin D toxicity were noted.

Table 3 Distribution of biochemical parameters by sex with corresponding p-values (Kruskal-Wallis test) 

Biochemical parameter Sex n Mean Standard deviation Minimum Maximum p
Uric acid (mg/dL) Female 51 4.939 0.913 2.700 7.300 0.727
Male 22 6.473 1.669 2.900 9.500
TSH (mU/mL) Female 51 2.115 1.231 0.790 6.870 0.693
Male 22 1.668 0.921 0.040 4.530
Vit. D (ng/mL) Female 51 17.160 5.382 7.700 34.210 0.011
Male 22 18.153 6.637 10.600 34.210
Estradiol (pg/mL) Female 51 129.843 96.615 28.000 506.000 0.778
Male 22 53.364 23.114 20.000 123.000
Testosterone (ng/dL) Female 51 0.974 1.467 0.130 6.790 0.154
Male 22 4.183 2.747 0.190 7.870
DHEAS (mcg/dL) Female 51 202.625 86.982 54.900 404.900 0.744
Male 22 271.777 171.668 77.300 832.400
Total cholesterol (mg/dL) Female 51 141.588 32.344 76.000 231.000 0.152
Male 22 133.455 25.069 73.000 176.000
Triglycerides (mg/dL) Female 51 77.980 27.335 37.000 170.000 0.989
Male 22 102.818 40.086 43.000 169.000
HDL (mg/dL) Female 51 49.392 8.300 32.000 69.000 0.099
Male 22 42.773 9.938 27.000 62.000
FBS (mg/dL) Female 51 82.588 7.052 70.000 110.000 0.769
Male 22 83.000 8.608 61.000 101.000
Insulin (mIU/L) Female 51 5.749 2.891 1.710 14.920 0.628
Male 22 5.642 0.913 1.260 7.300
HOMA-IR score Female 51 1.184 1.669 0.312 9.500 -
Male 22 1.208 1.231 0.236 6.870

TSH: thyroid-stimulating hormone; DHEAS: dehydroepiandrosterone sulphate; HDL: high-density lipoprotein; FBS: fasting blood sugar; HOMA-IR: homeostasis model assessment of insulin resistance.

According to the HOMA-IR criteria, 6.85% (n = 5) of patients had insulin resistance, out of which three were female and had a severe grade of acne. In line with the NCEP-ATP III criteria, 5.47% (n = 4) of patients had metabolic syndrome, out of which half had insulin resistance. However, no statistically significant association was found between acne severity and either metabolic syndrome or insulin resistance (Table 4). A statistically significant association was observed between BMI and the presence of metabolic syndrome (p = 0.007, Mann-Whitney U test), with higher BMI values noted among participants with metabolic syndrome. In contrast, the association between BMI and insulin resistance did not reach the predefined threshold for statistical significance (p = 0.026), though a trend toward higher BMI in insulin-resistant individuals was noted.

Table 4 Statistical associations between clinical variables and metabolic outcomes 

Association tested Statistical test p
Grade versus metabolic syndrome Mann-Whitney U 0.069
Grade versus insulin resistance Mann-Whitney U 0.305
BMI versus metabolic syndrome Mann-Whitney U 0.007
BMI versus insulin resistance Mann-Whitney U 0.026
Sex versus metabolic syndrome Fisher’s Exact 0.579
Sex versus insulin resistance Fisher’s Exact 0.634

BMI: body mass index.

Discussion

Acne vulgaris and metabolic syndrome may share overlapping pathogenic mechanisms, including chronic inflammation, oxidative stress, hormonal dysregulation, and nutrient-sensing pathway disturbances such as elevated mechanistic target of rapamycin complex 1 (mTORC1) activity. Increased mTORC1 signaling, observed in acne-prone skin, has been linked to insulin resistance and obesity, underscoring the complex interplay between dermatological and metabolic pathways10.

In our study, a total of 73 patients were included. 70% of our patients were female, which was akin to other studies showing a female preponderance11. The mean age of our patients was 22.2 ± 3.85, which is similar to another study by Chandak et al., where the mean age was 23.43 ± 3.99 years with predominantly mild to moderate grades of acne; however, in our study, the majority of patients had severe acne (grades 3 and 4)12. The predominance of severe acne in this study population may be partly shaped by the nature of a tertiary care setting, where individuals with persistent, distressing, or treatment-refractory acne are more inclined to seek specialized help either through formal referral or personal initiative. In the context of North-Eastern India, this could also reflect broader patterns, where access to early dermatological care is uneven, over-the-counter remedies are commonly used, and visible skin conditions carry a social weight that quietly urges people to seek help only when the burden becomes too much. These are possibilities that merit deeper, community-rooted inquiry.

According to the seven-day recall method, half of our study participants gave a history of consumption of home-cooked meals with a predominant component of vegetables and chicken. Refined oil and mustard oil were the most commonly used oils for the preparation of food. According to a study by Bansal et al., 23.33% of females gave a history of oily food intake regularly13. A high glycemic diet may trigger acne through disrupted nutrient signaling, leading to hyperkeratosis, hyper-seborrhea, and mTORC1 activation, alongside elevated androgen levels14. The mean waist circumference in our patients was 79.8 cm, which was comparable to another study by Kaya et al.15. Acne in industrialized countries signals aberrant nutrient-driven mTORC1 activation, linked to chronic diseases. Therefore, dermatologists should leverage dietary interventions to mitigate acne and prevent mTORC1-driven conditions16,17.

The mean moderate physical activity duration in our study participants was approximately 80 min/week, which is inconsistent with the recommended World Health Organization 2020 guidelines on physical activity and sedentary behavior18. In the present study, the median BMI of participants was 20.93 kg/m2 (interquartile range: 19.27-23.99 kg/m2), with 11.0% classified as overweight and 20.5% as obese, reflecting a combined prevalence of elevated BMI in 31.5% among the participants. Importantly, BMI demonstrated a statistically significant association with metabolic syndrome (p = 0.007) and a suggestive trend with insulin resistance (p = 0.026), reinforcing the metabolic implications of higher BMI even in a young population. In our study, serum biochemical parameters, including uric acid, TSH, testosterone, estradiol, DHEAS, lipid profile, fasting glucose, and insulin, were largely within normal physiological ranges across both sexes. Notably, no participants demonstrated thyroid dysfunction, suggesting a predominantly euthyroid status in contrast to findings by Bungau et al.19, where hypothyroidism or autoimmune thyroiditis was frequently observed among acne patients. However, vitamin D levels were generally low in our study population, with only three participants falling within the normal range. This aligns with a recent meta-analysis by Hasamoh et al.20, which found significantly lower serum vitamin D levels in acne patients compared to healthy controls and a negative correlation between vitamin D levels and acne severity. While these findings suggest a potential role of vitamin D in acne pathogenesis, our results highlight the importance of interpreting laboratory data within a broader clinical and contextual framework, especially in populations where baseline hypovitaminosis D may be widespread due to lifestyle or geographic factors, rather than assuming direct causality.

As per the HOMA-IR criteria and NCEP-ATP III, 7% patients had insulin resistance and 5.47% had metabolic syndrome, respectively; however, there was no significant association with acne severity. It was albeit not in consonance with other studies, which showed a statistically significant association between acne, metabolic syndrome, and/or insulin resistance21-24. However, this may be attributed to the overall low prevalence of metabolic syndrome in the north eastern part of India, which is supported by a study by Meher and Sahoo, revealing the states of Meghalaya and Assam to have the lowest prevalence of metabolic syndrome in the case of females (0.5%) and males (0.4%) respectively. In the same study, overall north-eastern India showed a prevalence of metabolic syndrome to be 0.7% in females and 0.5% in males25.

Several limitations must be acknowledged when interpreting our findings. First, the heterogeneous distribution of acne severity among participants may have diluted potential associations, especially in the absence of a control group. Second, the dietary data were collected using a 7-day recall period without a validated assessment tool, introducing potential recall bias and limiting the precision of dietary intake estimates. Third, the lack of age- and sex-matched healthy controls restricts our ability to draw definitive comparisons. These factors, combined with the cross-sectional design and relatively small sample size, suggest that our findings should be interpreted with caution and not extrapolated beyond the studied population. Future longitudinal studies with standardized dietary assessments and appropriate control groups are warranted to provide deeper insights into the metabolic underpinnings of acne, especially within diverse regional populations such as those in North-East India.

Conclusion

In this study from a tertiary care centre in North-Eastern India, no significant association was found between acne severity and metabolic syndrome or insulin resistance. Although over 30% of participants were overweight or obese, and vitamin D deficiency was widespread, these factors did not show a consistent association with acne severity. These findings highlight the multifactorial nature of acne, shaped by intricate metabolic and nutritional influences that may vary across populations. Given the study’s cross-sectional design, modest sample size, and absence of validated dietary tools or matched controls, the results should be interpreted within the unique clinical and nutritional landscape of North-Eastern India, without extrapolation to broader populations. Further longitudinal research is warranted to unravel these associations in more depth, especially in under-represented regions.

What does the study add?

This study contributes to evaluating the relationship between acne vulgaris and metabolic syndrome in patients from North-Eastern India, a population largely under-represented in dermatologic-metabolic research. Even though many participants presented with severe acne, the study did not identify a meaningful link with metabolic syndrome or insulin resistance. These findings challenge assumptions of universal dermato-metabolic linkage and emphasize the influence of regional variables, including diet, physical activity, and metabolic profile, on systemic inflammatory pathways in acne, along with underscoring the importance of conducting broader, multi-regional studies across ethnically and culturally diverse populations to better understand the potential metabolic underpinnings of acne.

REFERENCES

1. Sutaria AH, Masood S, Saleh HM, Schlessinger J. Acne vulgaris. In:StatPearls. Treasure Island, FL:StatPearls Publishing;2025. Available from:https://www.ncbi.nlm.nih.gov/books/nbk459173 [Last accessed on 2025 Jun 22]. [ Links ]

2. Bungau AF, Radu AF, Bungau SG, Vesa CM, Tit DM, Endres LM. Oxidative stress and metabolic syndrome in acne vulgaris:pathogenetic connections and potential role of dietary supplements and phytochemicals. Biomed Pharmacother. 2023;164:115003. [ Links ]

3. Adibi N, Robati RM. Skin and metabolic syndrome:a review of the possible associations. J Res Med Sci. 2021;26:16. [ Links ]

4. Hu Y, Zhu Y, Lian N, Chen M, Bartke A, Yuan R. Metabolic syndrome and skin diseases. Front Endocrinol (Lausanne). 2019;10:788. [ Links ]

5. Bae IH, Kwak JH, Na CH, Kim MS, Shin BS, Choi H. A comprehensive review of the acne grading scale in 2023. Ann Dermatol. 2024;36:65-73. [ Links ]

6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9. [ Links ]

7. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231-7. [ Links ]

8. The Jamovi Project. Jamovi (Version 2.6) [Computer Software];2025. Available from:https://www.jamovi.orgLinks ]

9. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice:a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16:177-89. [ Links ]

10. Fatima F, Das A, Kumar P, Datta D. Skin and metabolic syndrome:an evidence based comprehensive review. Indian J Dermatol. 2021;66:302-7. [ Links ]

11. Hasrat NH, Al-Yassen AQ. The relationship between acne vulgaris and insulin resistance. Cureus. 2023;15:e34241. [ Links ]

12. Chandak S, Singh A, Madke B, Jawade S, Khandelwal R. Acne vulgaris and metabolic syndrome:a possible association. Cureus. 2022;14:e24750. [ Links ]

13. Bansal P, Sardana K, Vats G, Sharma L, Garga UC, Khurana A. A prospective study examining trigger factors and hormonal abnormalities in adult female acne. Indian Dermatol Online J. 2020;4:544-50. [ Links ]

14. Romańska-Gocka K, Woźiak M, Kaczmarek-Skamira E, Zegarska B. The possible role of diet in the pathogenesis of adult female acne. Postepy Dermatol Alergol. 2016;33:416-20. [ Links ]

15. Kaya İF, Eryılmaz MA, Pekgör O, KülahçıE. Evaluation of the relationship between insulin resistance and visceral adiposity index in patients with acne vulgaris. Turk J Med Sci. 2022;52:477-83. [ Links ]

16. Melnik BC, John SM, Plewig G. Acne:risk indicator for increased body mass index and insulin resistance. Acta Derm Venereol. 2013;93:644-9. [ Links ]

17. Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis:an update. Clin Cosmet Investig Dermatol. 2015;8:371-88. [ Links ]

18. Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World health organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54:1451-62. [ Links ]

19. Bungau AF, Tit DM, Bungau SG, Vesa CM, Radu AF, Marin RC, et al. Exploring the metabolic and endocrine preconditioning associated with thyroid disorders:risk assessment and association with acne severity. Int J Mol Sci. 2024;25:721. [ Links ]

20. Hasamoh Y, Thadanipon K, Juntongjin P. Association between vitamin D level and acne, and correlation with disease severity:a meta-analysis. Dermatology. 2022;238:404-11. [ Links ]

21. Nagpal M, De D, Handa S, Pal A, Sachdeva N. Insulin resistance and metabolic syndrome in young men with acne. JAMA Dermatol. 2016;152:399-404. [ Links ]

22. Gruszczyńska M, Sadowska-Przytocka A, Szybiak W, Więckowska B, Lacka K. Insulin resistance in patients with acne vulgaris. Biomedicines. 2023;11:2294. [ Links ]

23. Andreadi A, Muscoli S, Tajmir R, Meloni M, Minasi A, Muscoli C, et al. Insulin resistance and acne:the role of metformin as alternative therapy in men. Pharmaceuticals (Basel). 2022;16:27. [ Links ]

24. Solanki AD, Solanki DK, Banker KK, Rangnani TC, Patel NM, Modi KR. Role of insulin resistance in patients of acne vulgaris and hirsutism in the western part of India- a cross-sectional study. Indian Dermatol Online J. 2023;14:38-43. [ Links ]

25. Meher T, Sahoo H. The epidemiological profile of metabolic syndrome in Indian population:a comparative study between men and women. Clin Epidemiol Glob Health. 2020;8:1047-52. [ Links ]

FundingNone.

Ethical considerations

Protection of humans and animals. The authors declare that the procedures followed complied with the ethical standards of the responsible human experimentation committee and adhered to the World Medical Association and the Declaration of Helsinki. The procedures were approved by the institutional Ethics Committee.

Confidentiality, informed consent, and ethical approval. The authors have followed their institution’s confidentiality protocols, obtained informed consent from patients, and received approval from the Ethics Committee. The SAGER guidelines were followed according to the nature of the study.

Declaration on the use of artificial intelligence. The authors declare that no generative artificial intelligence was used in the writing of this manuscript.

Received: April 24, 2025; Accepted: July 12, 2025

*Correspondence: Aniket Goswami E-mail: aniketgoswami07@gmail.com

Conflicts of interest

None.

Creative Commons License Portuguese Society of Dermatology and Venereology. Published by Permanyer. This is an open access article under the CC BY-NC-ND license